Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
| Brand name | AMLODIPINE AND OLMESARTAN MEDOXOMIL |
| Generic name | AMLODIPINE AND OLMESARTAN MEDOXOMIL |
| Active ingredient(s) | AMLODIPINE BESYLATE, OLMESARTAN MEDOXOMIL |
| Distributed by / for | Ascend Laboratories, LLC., Parsnippany, NJ 07054 |
| NDC | 67877-500-30 |
| Full product label | Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC., Parsnippany, NJ 07054. NDC: 67877-500-30 |
| Recalling firm | Ascend Laboratories, LLC |
| Distribution | Nationwide in the USA |
| Quantity | 6,192 bottles |
| Recall initiated | 2026-07-08 |
| Report date | 2026-07-29 |
| Recall completed | — |
| Recall number | D-0712-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Bedminster NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗